ACW 8.05% 9.4¢ actinogen medical limited

11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis, page-65

  1. 48 Posts.
    lightbulb Created with Sketch. 2
    Thanks for your thoughts - alas, behavioural tests are not the ultimate test nor is cellular memory in the form of LTP a post mortem examination : )

    I am seeking comfort from my investment in ACW via scrutiny of their scientific investigations, which maybe not published nor apparent.
    This is not unusual so in many ways it does not detract from the veracity of ACW as a being a good investment.

    Further, I am extremely pleased with their SP raise : )
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.007(8.05%)
Mkt cap ! $261.3M
Open High Low Value Volume
8.7¢ 9.9¢ 8.5¢ $1.642M 17.76M

Buyers (Bids)

No. Vol. Price($)
4 144098 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 70600 1
View Market Depth
Last trade - 14.09pm 18/07/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.